OPK logo

OPK OPKO Health, Inc.

NASDAQ Global Select · Medical - Diagnostics & Research · Healthcare

$1.57
-0.04 (-2.48%)

OPKO Health, Inc. operates as a healthcare enterprise with a dual focus on diagnostics and pharmaceuticals. Its operations span the United States, Ireland, Chile, Spain, Israel, Mexico, and other international markets. The company's Diagnostics division encompasses BioReference Laboratories, which delivers a comprehensive suite of laboratory testing services. These services are crucial for disease…

Market Cap: $1.17Bwww.opko.com

Price

No data yet.

Social Signal Score

39
5d
30
1 mentions
—
30d
38
5 mentions
—
60d
40
6 mentions
—
90d
47
10 mentions
—
news: 10

Analyst Ratings

13 analysts
Buyconsensus
Strong Buy 0Buy 9Hold 3Sell 1Strong Sell 0
Avg price target$3.13+99.4%
Low $2.25Median $3.13High $4
Current Consensus

Revenue

$65.41M-76.26%
$65.41M$225.33M$385.25M$545.16M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$-0.35
$-0.44–$-0.31
6 analysts
FY2026
$-0.21
$-0.24–$-0.19
4 analysts
FY2027
$-0.27
$-0.34–$-0.17
3 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Phillip Frost
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
2,275
Beta
1.53
Country
US
Piotroski score
4 / 9 (Middling)
Altman Z-score
-0.40
www.opko.com